Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer-Reference-Cited by-全球学者库

Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer

Published:2019-10-04 Issue:1 Volume:59 Page:75-81
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Papakonstantinou Antroula¹²,Hedayati Elham¹²,Hellström Mats³,Johansson Hemming³,Gnant Michael⁴⁵,Steger Günther⁵⁶⁷,Greil Richard⁵⁸,Untch Michael⁹,Moebus Volker¹⁰,Loibl Sibylle¹¹,Foukakis Theodoros¹²,Bergh Jonas¹²,Matikas Alexios¹²

Affiliation:

1. Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden;

2. Breast Cancer, Endocrine Tumours and Sarcoma Section, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden;

3. CKC, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden;

4. Department of Surgery, Medical University of Vienna, Vienna, Austria;

5. Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria;

6. Department of Medical Oncology, Medical University, Vienna, Austria;

7. Gaston H. Glock Research Center, Medical University, Vienna, Austria;

8. IIIrd Medical Department, Cancer Cluster Salzburg, Salzburg Cancer Research Institute, Paracelsus Medical University Salzburg, Salzburg, Austria;

9. Department of Obstetrics and Gynecology, Helios Klinikum Berlin-Buch, Berlin, Germany;

10. Department of Gynecology and Obstetrics, Klinikum Frankfurt Höchst, Academic Hospital of the Goethe University, Frankfurt, Germany;

11. German Breast Group, Neu-Isenburg, Germany

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2019.1670353

Reference36 articles.

1. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients

2. Impact of Chemotherapy Dose Intensity on Cancer Patient Outcomes

3. Mortality, length of stay, and health care costs of febrile neutropenia-related hospitalizations among patients with breast cancer in the United States

4. Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-up

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast cancer during pregnancy—The oncologist's point of view;Acta Obstetricia et Gynecologica Scandinavica;2023-11-20

2. A Prognostic Model Based on Nutritional Indexes for Patients with Pan-Cancer: A Real-World Cohort Study;2023-03-24

3. A Prognostic Model Based on Nutritional Indexes for Patients with Pan-Carcinomas: A Real-World Cohort Study;2023-01-30

4. Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study;npj Breast Cancer;2021-11-19

5. Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer;Clinical Breast Cancer;2021-10